Stay updated on TRK-250 in Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the TRK-250 in Idiopathic Pulmonary Fibrosis Clinical Trial page.

Latest updates to the TRK-250 in Idiopathic Pulmonary Fibrosis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedFooter revision label updated to v3.6.5, indicating a software maintenance update on the site. This change does not affect study content or data.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page shows a new revision label (v3.6.4) replacing the previous (v3.6.3). This indicates a small deployment update to the page template rather than changes to the study data.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page now displays revision v3.6.3, replacing v3.6.2. This indicates a minor maintenance update to the page version without changing study content.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page now shows a revised version tag, Revision: v3.6.2, replacing the previous v3.6.0. This reflects a minor platform update and does not change the study details or content presented on the page.SummaryDifference0.1%

- Check73 days agoChange DetectedThe page now states that recruitment is closed for the IPF study, reflecting completion; additional navigational updates were added (How to Read a Study Record, Common Questions, How to Join a Study) along with a site revision note (Revision: v3.6.0).SummaryDifference0.4%

- Check80 days agoChange DetectedRevision metadata updated from v3.5.4 to v3.5.5, indicating a new version of the page. The update appears to be administrative and does not reflect changes to the study details.SummaryDifference0.1%

Stay in the know with updates to TRK-250 in Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TRK-250 in Idiopathic Pulmonary Fibrosis Clinical Trial page.